Requests that the FDA: 1. Revise or issue new guidance (and initiate rulemaking as necessary) under 21 CFR Part 1271, Subpart C, to exempt or substantially streamline donor eligibility requirements (screening, physical examination, infectious disease testing, and eligibility determination) for directed/known reproductive donations